+49 711 500 989 80
deen

A potential new target for cancer immunotherapies



A potential new target for cancer immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a new study.

Materials provided by Weill Cornell Medicine. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th September 2022

Rhombic lip implicated in origins of high-risk medulloblastoma

Read more
27th September 2022

How prostate cancer may begin

Read more
27th September 2022

Diets rich in refined fiber may increase liver cancer risk in some individuals

Read more